论文部分内容阅读
目的探讨黛力新治疗脑卒中后肩手综合征并发抑郁的疗效及其对患侧上肢功能恢复的作用。方法对138例脑卒中后肩手综合征合并抑郁患者随机分为治疗组及对照组,常规治疗相同,治疗组采用黛力新治疗,对照组采用多塞平治疗,治疗前后采用汉密顿抑郁量表(HAMD)、抑郁自评量表(SDS)记录精神状态,用 Fugl-Meyer 量表和目测类比评分法(VHS)对患者上肢关节被动运动范围、上肢和腕关节的运动功能、疼痛及水肿程度并对比疗效。结果经治疗28 d 后两组对比,HAMD、SDS,评分及减分率比较差异有统计学意义(P<0.05),抑郁的治疗愈率、显效率及有效以及患者上肢功能的恢复差异均有统计学意义(P<0.05)。结论黛力新治疗脑卒中合并抑郁患者具有较好的疗效。
Objective To investigate the efficacy of Deanxit in the treatment of post-stroke shoulder-hand syndrome complicated with depression and its effect on functional recovery of affected upper limbs. Methods 138 cases of stroke patients with shoulder-hand syndrome with depression were randomly divided into treatment group and control group. The routine treatment was the same. The treatment group was treated with Deanxit and the control group was treated with doxepin. Before and after treatment, (HAMD) and depression self-rating scale (SDS) were recorded. The range of motion of upper extremity, motor function and pain of upper extremity and wrist were analyzed with Fugl-Meyer scale and visual analogue scale (VHS) The degree of edema and comparative efficacy. Results After treatment for 28 days, the scores of HAMD, SDS, score and rate of reduction were significantly different between the two groups (P <0.05). The cure rate, effective rate and effective rate of depression and recovery of upper limb function were Statistical significance (P <0.05). Conclusion Deanxit has good efficacy in the treatment of patients with stroke complicated with depression.